Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 33 (1) , 135-144
- https://doi.org/10.1016/j.nucmedbio.2005.09.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate designNuclear Medicine and Biology, 2005
- Measurement of the affinity and cooperativity of annexin V–membrane binding under conditions of low membrane occupancyAnalytical Biochemistry, 2004
- Apoptosis-detecting radioligands: current state of the art and future perspectivesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human useNuclear Medicine and Biology, 2003
- Monitoring Apoptosis in Real TimeThe Cancer Journal, 2002
- Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99TcmNuclear Medicine Communications, 2001
- Development and Characterization of Annexin V Mutants with Endogenous Chelation Sites for 99mTcBioconjugate Chemistry, 2000
- Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNAEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Preparation and Use of NHS-MAG3 for Technetium-99m Labeling of DNANuclear Medicine and Biology, 1997
- Comparative evaluation of 99Tcm-Hynic-HSA and 99Tcm-MAG3-HSA as possible blood pool agentsNuclear Medicine Communications, 1995